UK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough therapies in high-impact areas

Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators. As part of this first-of-its-kind regulatory collaboration between…

Read MoreUK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough therapies in high-impact areas

National Competent Authorities to launch a fast-track approach for the authorisation of multinational clinical trials in the EU/EEA

On 27 November 2025, a large number of National Competent Authorities (NCAs) and Ethics Committees committed to test a coordinated fast-track approach for evaluating multinational clinical trials. About the FAST-EU (Facilitating and Accelerating Strategic Trials) initiative When is the FAST-EU…

Read MoreNational Competent Authorities to launch a fast-track approach for the authorisation of multinational clinical trials in the EU/EEA

MHRA and NICE launch an aligned pathway to publish regulatory and health technology assessment decisions simultaneously

The MHRA and the National Institute for Health and Care Excellence (NICE) have launched an aligned pathway. This is a joint initiative designed to streamline the scheduling of the regulatory approval and health technology assessment processes in order to reduce…

Read MoreMHRA and NICE launch an aligned pathway to publish regulatory and health technology assessment decisions simultaneously